Search

Your search keyword '"Sharpe, Rowena"' showing total 18 results

Search Constraints

Start Over You searched for: Author "Sharpe, Rowena" Remove constraint Author: "Sharpe, Rowena"
18 results on '"Sharpe, Rowena"'

Search Results

1. The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care

2. Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial

3. Correction to: The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care

4. The National Lung Matrix Trial of personalized therapy in lung cancer

5. TESSA JOWELL BRAIN MATRIX PLATFORM STUDY: PRELIMINARY ANALYSIS OF THE PRIMARY FEASIBILITY & PROCESS-CENTRED OBJECTIVE

6. Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme

8. The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care

9. Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer

10. Protocol for the Tessa Jowell BRAIN MATRIX Platform Study

11. Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial

12. CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults

13. Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised adaptive trial

14. CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults

17. Emerging findings in the Cancer Research UK stratified medicine program.

18. Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial

Catalog

Books, media, physical & digital resources